semaglutide alcohol use disorder study Wegovy and Ozempic (semaglutide) are associated with a 50-56% reduction in addiction A Lancet RCT just showed

2025;27(Supplement_5):v247-v255

FIGURE 1 3.2 General information A total of 20 cases from five countries were included, including 7 males and 13 females, with ages ranging from 29 to 83 years

This mechanism is distinct from growth hormone secretagogues, incretin mimetics, or direct receptor agonistsmeaning AHK-Cu doesn't compete for the same binding sites as GLP-1 analogs, growth hormone releasing peptides, or melanocortin receptor targets

The most common side effects of semaglutide are gastrointestinal in nature, with nausea occurring in up to 44% of patients in Wegovy clinical trials

Encouraged by the growing evidences on the protective effect of ebselen against oxidative injury, Tak et al